{"DataElement":{"publicId":"3176031","version":"1","preferredName":"Performed Observation Outcome Data ISO21090.ANY.v1.0","preferredDefinition":"Data or information that is determined by an act of observation. EXAMPLE(S): The result of a lab test, physical finding, self-reported symptom. The adverse event term code.","longName":"3174905v1.0:2846959v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3174905","version":"1","preferredName":"Performed Observation Outcome Data","preferredDefinition":"Executed and carried through to completion.:Watching something and taking note of what happens.:The result of an action._A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn.","longName":"2867619v1.0:2423441v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2867619","version":"1","preferredName":"Performed Observation Outcome","preferredDefinition":"Executed and carried through to completion.:Watching something and taking note of what happens.:The result of an action.","longName":"C38000:C25598:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Observation","conceptCode":"C25598","definition":"Watching something and taking note of what happens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69416FE9-3E58-ED41-E040-BB89AD4365EB","latestVersionIndicator":"Yes","beginDate":"2009-05-06","endDate":null,"createdBy":"UMLLOADER_BRIDGPRD","dateCreated":"2009-05-06","modifiedBy":"ONEDATA","dateModified":"2009-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2423441","version":"1","preferredName":"Data","preferredDefinition":"A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn.","longName":"C25474","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Data","conceptCode":"C25474","definition":"A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0434A1D4-F36A-54A9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-28","endDate":null,"createdBy":"UMLLOADER_DUKE_P","dateCreated":"2005-10-28","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97F34498-D0A9-9F6A-E040-BB89AD4326CE","latestVersionIndicator":"Yes","beginDate":"2010-12-21","endDate":null,"createdBy":"UMLLOADER_BRIDGPRD","dateCreated":"2010-12-21","modifiedBy":"DWARZEL","dateModified":"2022-05-08","changeDescription":"DEC released per model owner approval.  mc 2/2/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2846959","version":"1","preferredName":"ISO21090.ANY.v1.0","preferredDefinition":"Defines the basic properties of every data value.","longName":"2846959v1.0","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"ISO21090ANYv1.0","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2846956","version":"1","preferredName":"ISO21090 Data Types","preferredDefinition":"Health Informatics - Harmonized data types for information interchange","longName":"ISO21090 DATA TYPES","context":"NCIP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64793C86-27A4-C8B7-E040-BB89AD4337FF","latestVersionIndicator":"Yes","beginDate":"2009-03-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-03-06","modifiedBy":"CURTIST","dateModified":"2009-06-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234203","version":"1","preferredName":"Text","preferredDefinition":"Text; the words of something written.","longName":"C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F89B-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ISO:International Organization for Standardization","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64794539-8A21-4FD2-E040-BB89AD43186D","latestVersionIndicator":"Yes","beginDate":"2009-03-06","endDate":null,"createdBy":"LEEB","dateCreated":"2009-03-06","modifiedBy":"LEEB","dateModified":"2009-03-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2714898","version":"3.02","longName":"BRIDG 3.0.2","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2867548","version":"1","longName":"gov.nih.nci.BRIDG.domain","context":"NCIP"}]},{"publicId":"3757111","version":"3.2","longName":"BRIDG 3.2","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3757156","version":"1","longName":"gov.nih.nci.BRIDG.domain.StudyConductSubDomain","context":"NCIP"}]}],"AlternateNames":[{"name":"PerformedObservationResult:result","type":"UML Class:UML Attr","context":"NCIP"},{"name":"gov.nih.nci.BRIDG.domain.PerformedObservationResult.result","type":"UML Qualified Attr","context":"NCIP"},{"name":"gov.nih.nci.BRIDG.domain.StudyConductSubDomain.PerformedObservationResult.value","type":"UML Qualified Attr","context":"NCIP"},{"name":"PerformedObservationResult:value","type":"UML Class:UML Attr","context":"NCIP"},{"name":"CDE 2737130:Disease, Disorder or Finding.What was the clinically significant co-existing disease or organ impairment?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760760:Diagnosis.What is the gastrointestinal diagnosis type?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2936204:Abnormal Cell.Were cytogenetic abnormalities present at diagnosis?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2871885:Procedures.What is the cm H2O value of the cerebrospinal fluid closing pressure:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2686188:Lab Results.For the systemic lupus erythematosus, what was the ds DNA test result?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"FemaleReproductiveCharacteristic.liveBirthCount","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2686147:Diagnosis.Specify the other arthritis:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2677072:Disease, Disorder or Finding.If the breast cancer was in the state of relapse at the time of transplantation, was the cancer local or metastatic?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2681691:Chronic or Associated Diseases and Exposures.What was the recipient's test results for the presence of CMV-antibodies?(Chronic)","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2771967:Lab Results.NK cells exponent value:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2962060:Involvement and Extent of Disease.What was the extent stage of the CNS tumor?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2957357:UML DEFAULT CD.Progesterone Receptor status","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2181363v1.0:  Myeloma Diagnosis Stage","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"Base Result.Reported Text Result","type":"Map:CDISCLabv1.0.1","context":"NCIP"},{"name":"Vital.ht","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Pro_CM.pro_mode","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"NOTE.note_text","type":"Map:OMOPv5.2","context":"NCIP"},{"name":"CDE 2952877:Lab Results.Urinary monoclonal light chains:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2770702:Biological Process.Specify the etiology of the other organism:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3028423:Lab Results.Indicate the enzyme that was evaluated for activity level:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2780171:Lab Results.Chimerism study cell type:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3179200:Lab Results.Does the recipient have clinical significant aspergillus fungal infection history?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2003874v3.0: Medical History Description","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2780721:Lab Results.Chimerism study total cells examined:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2704135:Lab Results.DR51 specificity present?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2815530:Individuals.What is the combined househould gross annual income?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760860:Diagnosis.What is the liver diagnosis type?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"MeddraVersion.name > AdverseEventMeddraLowLevelTerm","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2689272:Diagnosis.What was the classification of the immune deficiency?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 323v3.0: Common Toxicity Criteria Adverse Event Term Type","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2693568:Lab Results.Test results of infectious disease marker for hepatitis B virus (HBV) surface antigen(HBsAg)","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2182896:Chronic or Associated Diseases and Exposures.Have you smoked at least 100 cigarettes in your entire life?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2183360v2.0: Laboratory Test Result Numeric Value","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2704184:Lab Results.Second DQA1* allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3008133:Disease, Disorder or Finding.Specify the cardiac status:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"ParticipantHistory.weight","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2692300:Diagnosis.Specify the other juvenile idiopathic arthritis:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760374:Lab Results.CD4+ cells exponent value:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760286:Lab Results.Total value of CD34+ cells:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2797534:Diagnosis.Specify the clinical sign, symptom or evaluation used to diagnose liver toxicity:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2694887:Lab Results.First DPB1* allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3073243:Lab Results.What is the reason for the DPA1 allelles missing value?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3123697:Disease, Disorder or Finding.What were the results for the tympanometry assessment?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2180758:Disease, Disorder or Finding.Shortening Fraction","type":"Map:HCTv1.0","context":"NCIP"},{"name":"MD Anderson Specific Content: Product.Fresh product","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2784439:Lab Results.For the bacterial or fungal infection cultures performed prior to infusion, specify the 6th organism with name(s):","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3028432:Lab Results.What is the unit of measure for enzyme evaluated for activity level?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2768641:Outcome of Therapy.Specify the other HSCT related main cause(s) of death:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2685066:Diagnosis.Specify the type of other B-cell lymphoma:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2494565:Diagnosis.What was the primary disease for which the HSCT was performed?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2693502:Lab Results.Number of A antigens provided:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"MD Anderson Specific Content: Product.Frozen product","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2785785:Activity.Were the secondary containers (e.g., insulated shipping containers and unit cassette) intact when they arrived at your center?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"ObservationResult.resultQuantity","type":"Map:CTRPv3.8","context":"NCIP"},{"name":"CDE 62732//:Therapy Results.Has residual primary tumor been detected (after resection)?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2861058:Lab Results.Serum beta 2 microglobulin value:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2861157:Lab Results.What is the percent of blasts in the bone marrow?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2693570:Lab Results.Second DRB1* allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2785867:Activity.Was the cord blood unit completely frozen when it arrived at your center?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2780118:Lab Results.What is the value of hemoglobin?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760532:Diagnosis.What is the CNS / psychiatric diagnosis type?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2795891:Outcome of Therapy.Overall severity of chronic GVHD:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2695343:Lab Results.First DQ antigen specificity:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"AdverseEvent.verbatim","type":"Map:C3PRv2.9","context":"NCIP"},{"name":"CDE 2939877:Diagnosis.Specify the number of phases experienced:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760281:Diagnosis.What is the cardiovascular diagnosis type?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2798645:Personal attributes.What is the blood type and Rh factor?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2685390:Diagnosis.Specify the other constitutional anemia:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"AdverseEventAssessment.text (in IndividualCaseSafetyReport)","type":"Map:ICSRr2","context":"NCIP"},{"name":"CDE 2705050:Lab Results.Second DRB3* allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"LabResult.referenceTextList","type":"Map:Lab","context":"NCIP"},{"name":"MD Anderson Specific Content: Product.Mesenchymal cells","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760290:Lab Results.CD34+ cells exponent value:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2693528:Lab Results.Second A* allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2749801:Lab Results.Were tumor cells detected in bone marrow, in the interval between last systemic therapy and collection prior to HSCT?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3125302v1.1: Common Terminology Criteria for Adverse Events Version 4.0 Low Level Term Name","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"MD Anderson Specific Content: Product.Hematopoietic stem cells","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3061554:Lab Results.Serum beta-human chorionic gonadotropin value:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2676358:Therapies.Did graft failure occur?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2704098:Lab Results.Bw4 specificity present?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2729902:Lab Results.For the bacterial or fungal infection cultures performed prior to infusion, specify the results:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2695275:Lab Results.First B antigen specificity:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760306:Lab Results.CD3+ cells exponent value:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"InvestigativeSubject.gestationPeriod","type":"Map:AE","context":"NCIP"},{"name":"ClinicalResult.value","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 3020044:Disease, Disorder or Finding.What is the central nervous system abnormality type?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2003853:Pre-Preparative Regimen.Performance Status","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2985301:Lab Results.Specify the chimerism laboratory procedure cell type:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"ObservationResult.resultText","type":"Map:CTRPv3.8","context":"NCIP"},{"name":"CDE 2695347:Lab Results.Second DQ antigen specificity:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2695021:Lab Results.Test results of infectious disease marker for hepatitis C virus (HCV) antibody (Anti-HCV)","type":"Map:HCTv1.0","context":"NCIP"},{"name":"LaboratoryResult.numericPrecision","type":"Map:LabViewer2.2","context":"NCIP"},{"name":"CDE 2686127:Diagnosis.Specify the other immune deficiency:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2902378v1.0: Prostate Carcinoma Whitmore-Jewett System Stage","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"VerificationEvent.value","type":"Map:HL7SP","context":"NCIP"},{"name":"CDE 2798697:Occurrences.Which malignancy(ies) occurred?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 58208 /:Diagnosis.Rai Stage Classification","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2798778:Lab Results.What is the unit of measure for LDH?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3212372:Lab Results.Were host cells present as determined by non-quantitative means?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2965215:Chronic or Associated Diseases and Exposures.Was maternal engraftment present?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2685061:Diagnosis.Specify the type of non-hodgkin lymphoma:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2686173:Diagnosis.Specify the other autoimmune bowel disorder:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2685070:Diagnosis.Specify the other T / NK cell lymphoma:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2724626:Diagnosis.Primary cancer type","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3419407v1.0: Breast Cancer American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"Base Result.Reported Units","type":"Map:CDISCLabv1.0.1","context":"NCIP"},{"name":"PerformedLesionDescription.perineuralInvasion","type":"Map:LSDAMv2.2.3Plus","context":"NCIP"},{"name":"PerformedPathologicalStaging.primaryTumorStage","type":"Map:LSDAMv2.2.3Plus","context":"NCIP"},{"name":"Death_Cause.death_cause_code","type":"Map:PCORNetv3.1","context":"NCIP"},{"name":"Lab_Result_CM.result_qual","type":"Map:PCORNetv3.1","context":"NCIP"},{"name":"CDE 2950698:Lab Results.What is the lymphoma histology type?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3103994:Biological Process.What was the sensitivity of the lymphoma to chemotherapy?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2802820:Lab Results.What is the value of the cluster of differentiation?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2965920:Lab Results.What is the IgA level?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2695328:Lab Results.Number of DQ antigens provided:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2748995:Techniques.Was a particular tumor cell detection method used after purging?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2704199:Lab Results.Number of DP antigens provided:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"AbstractMeddraDomain.icd9Code","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 3118470:Medical Records and Forms.Search result:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2799093:Lab Results.What is the unit of measure for platelets?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3073233:Lab Results.What is the reason for the DRB5 allelles missing value?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2873940:Diagnostic or Prognostic Factor.Test results of infectious disease marker for Epstein-Barr antibody:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2936194:Lab Results.Specify BCR/ABL or other molecular tests results:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2939876:Disease, Disorder or Finding.Specify the number of blast phases:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2689324:Lab Results.For the systemic lupus erythematosus (SLE), what was the C4 test result?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"PerformedObservationResult.categoryCode","type":"Map:CTRv1.0","context":"NCIP"},{"name":"CDE 2728988:Adverse Events.Specify the life-threatening complications that the donor experienced during or after the collection:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2775909:Lab Results.What is the unit of measure for hemoglobin?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2787346:Disease, Disorder or Finding.Specify the result of the diagnosis based on evidence from the biopsy (histology):","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2860212:Lab Results.What was the status of the monocyte finding?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2861135:Lab Results.What was the percentage of plasma cells in bone marrow from the unknown source?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2968379:Individuals.Specify other genetic disease:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Participant.employmentStatusOtherText","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2770662:Biological Process.Specify the etiology of the other virus:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2940579:Diagnosis.Specify which accelerated phase symptoms were present:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3073239:Lab Results.What is the reason for the DQA1 allelles missing value?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"AdverseEventResponseDescription.eventDescription","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2679800:Diagnosis.Specify the other inherited disorder of metabolism:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2729172:Lab Results.What was the unit of measure for the total volume of the product being analyzed?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2962097:Disease, Disorder or Finding.Was there a family history of cancer in first degree relatives under 40 years of age?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2695308:Lab Results.First DR antigen specificity:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Base Result.Reported Numeric Result","type":"Map:CDISCLabv1.0.1","context":"NCIP"},{"name":"Base Result.Reported Numeric Result Precision","type":"Map:CDISCLabv1.0.1","context":"NCIP"},{"name":"PerformedPathologicalStaging.numberLymphNodesInvolved","type":"Map:LSDAMv2.2.3Plus","context":"NCIP"},{"name":"SECTION VII FIRST COURSE OF THERAPY - SURGICAL PROCEDURE OF OTHER SITE","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION VII FIRST COURSE OF THERAPY - HORMONE THERAPY","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION VIII FOLLOW UP INFORMATION - SURVIVAL DATA ITEMS - Surv-Flag Active Followup","type":"Map:SEER 2015","context":"NCIP"},{"name":"Base Result.SI Numeric Result","type":"Map:CDISCLabv1.0.1","context":"NCIP"},{"name":"Vital Signs.Diastolic","type":"Map:Sentinelv6.0.2","context":"NCIP"},{"name":"Encounter.discharge_status","type":"Map:PCORNetv3.1","context":"NCIP"},{"name":"Diagnosis.dx","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Diagnosis.dx_type","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Death_Cause.death_cause_code","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Lab_Result_CM.result_snomed","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Vital.wt","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Condition.condition","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Pro_CM.pro_measure_scaled_tscore","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Diagnosis.DIAGNOSIS_CODING_SYSTEM","type":"Map:i2b2/ACTv1.4","context":"NCIP"},{"name":"MEASUREMENT.operator_concept_id","type":"Map:OMOPv5.2","context":"NCIP"},{"name":"Lab_Result_CM.result_num","type":"Map:PCORNetv3.1","context":"NCIP"},{"name":"Vital.systolic","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Obs_Gen.obsgen_result_unit","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Diagnosis.DIAGNOSIS_CODING_SYSTEM_VERSION","type":"Map:i2b2/ACTv1.4","context":"NCIP"},{"name":"OBSERVATION.value_as_number","type":"Map:OMOPv5.2","context":"NCIP"},{"name":"CDE 2772026:Disease, Disorder or Finding.Specify genetic disease:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3010917:Diagnosis.What is the type of Batten disease?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2201348v1.0: Adverse Event Suspected Other Attribution Text Name","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2771987:Lab Results.Mesenchymal cells exponent value:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3419395v1.0: Breast Cancer American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Regional Lymph Node N Stage","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2682913:Lab Results.For the systemic lupus erythematosus, what was the test results at diagnosis for the other antibody?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"LabResult.textResult","type":"Map:Lab","context":"NCIP"},{"name":"AbstractMeddraDomain.meddraCode > AdverseEvent","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"AdverseEventResponseDescription.presentStatus","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2180456:Lab Results.Hepatitis B surface antibody Status","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2860221:Lab Results.Absolute number of plasma cells in blood value:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2986133:Lab Results.What is the value of leukocyte enzyme activity level?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CtcTerm.select > AdverseEventCtcTerm","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2963549:Lab Results.Did hypercalcemia occur?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3061152:Lab Results.What is the percentage of hematocrit?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760372:Lab Results.Total value of CD4+ cells:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"SAEReportPreExistingCondition.other","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2769602:Adverse Events.Specify other illness cause of the adverse event:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"DiseaseHistory.otherPrimaryDisease","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2760540:Diagnosis.Specify the other CNS / psychiatric diagnosis:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2954522:Involvement and Extent of Disease.Specify the lymphoma stage of organ involvement:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2695088:Lab Results.Test results of infectious disease marker for syphilis using serologic testing for syphilis(STS)","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Assessment.codedInterpretation","type":"Map:AE","context":"NCIP"},{"name":"CDE 2795147:Lab Results.What is the percentage of neutrophils?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2677061:Disease, Disorder or Finding.If the breast cancer was in the state of relapse at the time of transplantation, what was the number of the relapse?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2685046:Disease Response.If there was a relapse of hodgkin lymphoma at the time of transplantation, what was the sensitivity to chemotherapy?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2769129:Involvement and Extent of Disease.Specify contributing cause of death:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"FemaleReproductiveCharacteristic.stillBirthCount","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2860890:Lab Results.What is the percentage of plasma cells in bone marrow biopsy?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2967342:Individuals.Specify relationship:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2969621:Lab Results.Was the biopsy site positive for neuroblastoma?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2695092:Lab Results.Test results of infectious disease marker for cytomegalovirus(CMV) antibody (IgG or total):","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2802822:Lab Results.What is the unit of measure for the cluster of differentiation?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"MD Anderson Specific Content: Transplant.Total number of cells infused","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2630453:Lab Results.Specify test results for test performed on other infectious disease marker","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2974069:Involvement and Extent of Disease.What is the Pediatric Oncology Group Stage?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2746517v1.0: Adverse Event Outcome Type","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2634596:Lab Results.Hepatitis B - DNA status","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2965899:Lab Results.What is the IgG level?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2954687:Symptoms.Specify the systemic symptoms:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3017711:Molecular Abnormality.Were cytogenetics tested?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3073226:Lab Results.What is the reason for the DRB3 allelles missing value?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3419387v1.0: Breast Cancer American Joint Committee on Cancer (AJCC) Edition 7 Clinical Tumor T Stage","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2694945:Lab Results.Test results of infectious disease marker for hepatitis B virus (HBV) core antibody (Anti HBc)","type":"Map:HCTv1.0","context":"NCIP"},{"name":"SECTION IX ADMINISTRATIVE CODES - OVER-RIDE FLAG FOR SITE/EOD/DIAGNOSIS DATE (IF40)","type":"Map:SEER 2015","context":"NCIP"},{"name":"Vital Signs.Systolic","type":"Map:Sentinelv6.0.2","context":"NCIP"},{"name":"Vital.systolic","type":"Map:PCORNetv3.1","context":"NCIP"},{"name":"Lab_Result_CM.result_qual","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Obs_Clin.obsclin_result_text","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Laboratory Test.RESULT_UNIT","type":"Map:i2b2/ACTv1.4","context":"NCIP"},{"name":"NOTE.language_concept_id","type":"Map:OMOPv5.2","context":"NCIP"},{"name":"CDE 2676557:Diagnosis.Was the breast cancer inflammatory or non-inflammatory?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760129:Lab Results.Mononucleated cells exponent value:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3073220:Lab Results.What is the reason for the B alleles missing value?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2695323:Lab Results.Second DR antigen specificity:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2859803:Lab Results.Plasma cells in blood percentage value:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760804:Diagnosis.What is the genitourinary diagnosis type?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2738465:Disease, Disorder or Finding.What was the cause of the therapy-related MDS/MPS?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2875642:Individuals.Weight","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2986435:Disease, Disorder or Finding.What was the prognosis type of seminoma?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2952899:Lab Results.What is the unit of measure for serum immunoglobulin light chain, Kappa?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3104029:Lab Results.ER % cells stained positive:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2816459:Behavior.What is the average number of packs of cigarettes smoked per day?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2875701:Physical Description of Individuals.What is the dosing body weight unit of measure?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3086802:Units of Measure.What is the unit of measure for serum IgG?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2950614:Lab Results.What was the status of the serum immunofixation finding?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2935457:Disease Response.Specify the degree of disease response to treatment(s):","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2685162:Diagnosis.Specify the other histiocytic disorder:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2815349:Disease, Disorder or Finding.How many prior HSCTs have been done?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"QualitativeEvaluation.painIndexCode","type":"Map:CTOM","context":"NCIP"},{"name":"ObservationEvent.value (in IndividualCaseSafetyReport)","type":"Map:ICSRr2","context":"NCIP"},{"name":"CDE 3010717:Diagnosis.What is the inheritance of immune deficiency?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2982953:Lab Results.What is the percentage of the percent of cells positive for neuroblastoma?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2961440:Lab Results.What is the stroma-rich histology?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3158516:Medical Records and Forms.Specify other indication for CIBMTR recipient ID (CRID) assignment:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2771962:Lab Results.Total value of NK cells:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2784429:Lab Results.For the bacterial or fungal infection cultures performed prior to infusion, specify the 1st organism with name(s):","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2965430:Symptoms.Did chronic diarrhea occur ?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2953272:Individuals.Specify other health insurance:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2686104:Diagnosis.Specify the other hemoglobinopathy:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760127:Lab Results.Total value of mononucleated cells:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2558043:Disease Response.What was the recipient's survival status at latest follow-up?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2686182:Lab Results.For the systemic lupus erythematosus, what was the ANA test result?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2704175:Lab Results.First DQA1* allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2952921:Lab Results.What is the value of serum creatinine?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"ClinicalResult.valueUnitOfMeasureCode","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2798766:Lab Results.What is the LDH lab value?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"AdverseEventResponseDescription.causeOfDeath","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2895871:Disease, Disorder or Finding.What type of the cell origin of the new malignancy is it?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3081978:Diagnosis.What was the subtype for which the HSCT was performed?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2912001:Diagnosis.What was the classification of the congenital abnormalities of erythrocyte differentiation or function?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"AbstractMeddraDomain.icd10Code","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2793779:Diagnosis.What was the type of chronic GVHD onset?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3057303:Quality of Life.What was the Vineland adaptive behavior scales value?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760071:Diagnosis.Specify the other autoimmune disease diagnosis:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2795420:Lab Results.Did the recipient recover and maintain ANC greater than or equal to 500/mmE3 following the decline?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2538246v1.0: MedDRA Adverse Event Code","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2685380:Diagnosis.Specify the other type of leukemia:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2986478:Disease, Disorder or Finding.Specify testicular non-seminomatous germ cell tumor prognosis:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"SECTION IX ADMINISTRATIVE CODES - LEUKEMIA OR LYMPHOMA/DIAGNOSTIC CONFIRMATION INTERFIELD REVIEW","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION VIII FOLLOW UP INFORMATION - SURVIVAL DATA ITEMS - Surv-Mos Presumed Alive","type":"Map:SEER 2015","context":"NCIP"},{"name":"Base Result.SI Units","type":"Map:CDISCLabv1.0.1","context":"NCIP"},{"name":"CDE 2695284:Lab Results.Second B antigen specificity:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2679527:Diagnosis.Specify the type of other solid tumor:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2705046:Lab Results.First DRB3* allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2691365:Lab Results.For the polymyositis-dermatomyositis, were the biopsy results typical of the disease?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2685158:Diagnosis.What was the classification of the histiocytic disorder?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2964752:Lab Results.What is the status of T-cell engraftment?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2798679:Property or Attribute.Have you smoked cigarettes within the past year?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2181363:Diagnosis.Durie-Salmon Stage","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2932807:Disease, Disorder or Finding.Specify prior disease:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2686200:Lab Results.What was the CPK test result?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2695029:Lab Results.Test results of infectious disease marker for human immunodeficiency virus(HIV)-1 p24 antigen:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"AbstractMeddraDomain.icd9CmCode","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"MD Anderson Specific Content: Recipient.Recipient body surface area (m^2)","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2786671:Activity.Was the primary container (e.g.,cord blood unit bag) intact upon thawing?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3181148:Lab Results.Specify neutrophils one decimal place billion per liter value:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2967327:Individuals.Are other family members known to have neuroblastoma or ganglioneuroma?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2181361:Diagnosis.Durie-Salmon Sub-stage","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2002838:Procedures.Total number of axillary lymph nodes examined","type":"Map:HCTv1.0","context":"NCIP"},{"name":"AdverseEventResponseDescription.eventAbate","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2974122:Disease, Disorder or Finding.Specify other aplastic anemia etiology:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3141318:Lab Results.Specify test sensitivity to cross-linking agents test results:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2939856:Disease, Disorder or Finding.How many blast phases occurred?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2977753:Lab Results.Specify the histologic findings by Shimada classification:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 58208v3.0: CLL Leukemia RAI Stage","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2760905:Diagnosis.Specify the other diagnosis:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3030987:Lab Results.What is the value of serum free light chains lambda?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CancerStage.stageCodeSystem","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2953024:Lab Results.What is the value of serum monoclonal M protein?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2603692:Outcome of Therapy.What was the maximum Grade of acute graft versus host disease","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3009223:Disease, Disorder or Finding.Specify the renal status:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2815058:Personal attributes.Is the person an adult or emancipated minor?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"AbstractMeddraDomain.costartSymbol","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2965306:Disease, Disorder or Finding.What is the cause of disease type ?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2538920:Units of Measure.Height Unit of Measure UCUM Code","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2866117:Lab Results.Cerebrospinal fluid(CSF) total protein value:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2180578:Disease, Disorder or Finding.Left Ventricular Ejection Fraction at Rest","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Death_Cause.death_cause","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Condition.condition_type","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"CDE 2435038v1.0: Protocol Deviation Description Text","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 3073237:Lab Results.What is the reason for the DPB1 allelles missing value?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3419393v1.0: Breast Cancer American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Tumor T Stage","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2749841:Lab Results.For the systemic sclerosis, what was the laboratory procedure type?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"AdverseEvent > AbstractAdverseEventTerm","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2861069:Lab Results.What is the unit of measure for serum albumin?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3086814:Lab Results.What is the oxygen saturation level percentage?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"InvestigationCharacteristic.value (in IndividualCaseSafetyReport)","type":"Map:ICSRr2","context":"NCIP"},{"name":"ProductObservation.value","type":"Map:AE","context":"NCIP"},{"name":"CDE 2950619:Lab Results.Specify monoclonal immunoglobulin result:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2729161:Lab Results.Total volume of product:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2686171:Diagnosis.Specify the other autoimmune cytopenia:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2902443v1.0: Hodgkin's Lymphoma Modified Ann Arbor Staging System Stage","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2005035:Lab Results.Hemoglobin","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2682630:Diagnosis.What was the W.H.O classification of the acute myelogenous leukemia (AML) or acute nonlymphocytic leukemia (ANLL)?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760894:Diagnosis.What is the pulmonary diagnosis type?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2861046:Lab Results.What is the percent of blasts in blood?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2002839:Lab Results.Number of positive axillary lymph nodes","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2681693:Pre-Preparative Regimen.What was the donor test results for the presence of CMV-antibodies?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2965903:Lab Results.What is the IgM level?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3204062:Individuals.What adjusted body weight was used?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760234:Lab Results.Total value of nucleated cells:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2965492:Lab Results.What is the natural killer cell function?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2679566:Disease, Disorder or Finding.What was the classification of the platelet disorder?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2965208:Lab Results.What is the percentage of lymphocytes?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Person.numberOfSiblings","type":"Map:AE","context":"NCIP"},{"name":"CDE 3129551:Involvement and Extent of Disease.What was the Binet stage?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2965477:Lab Results.What is the status of B-cell function?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2971761:Lab Results.Were any other molecular abnormalities present?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"AdverseEvent.descriptionText","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2682005:Therapies.As part of a toxicity modifying regimen, was FGF (velafermin) started or is there a plan to use it?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3031295:Lab Results.What is the value of urinary monoclonal light chains?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Participant.employmentStatusCode","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2955919:Lab Results.Specify cell line:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2967344:Individuals.Number affected:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2953026:Lab Results.What is the serum M protein unit of measure?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2729065:Adverse Events.If the donor died as a result of the collection, specify the cause of death:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2967232:Lab Results.What is the value of homovanillic acid?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2756919:Lab Results.What is the value of the immunoglobulin test?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3181250:Lab Results.Specify drug level:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2704246:Lab Results.First DP antigen specificity:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2744521:Techniques.Specify portion manipulated:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"MD Anderson Specific Content: Product.NK cells","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2676535:Biological Process.If there was a relapse of non-hodgkin lymphoma at the time of transplantation, what was the sensitivity to chemotherapy?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2950916:Lab Results.Immunochemical Type","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760261:Lab Results.Nucleated cells exponent value:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3057316:Lab Results.What is the value of the cerebrospinal fluid total protein measurement?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3135354:Organ Measurements.Specify the spleen size below costal margin in centimeters:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"SubjectStratificationAnswer","type":"Map:C3PRv2.9","context":"NCIP"},{"name":"CDE 2694875:Lab Results.First DQB1* allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2967346:Individuals.Number unknown:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"LaboratoryResult.textResult","type":"Map:LabViewer2.2","context":"NCIP"},{"name":"CDE 2874163:Individuals.Height","type":"Map:HCTv1.0","context":"NCIP"},{"name":"QualitativeEvaluation.painIndexCodeSystem","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2971763:Lab Results.Specify other molecular abnormality:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Base Result.Conventional Units","type":"Map:CDISCLabv1.0.1","context":"NCIP"},{"name":"SubjectEligibilityAnswer.answerText","type":"Map:C3PRv2.9","context":"NCIP"},{"name":"CDE 2676483:Diagnosis.Specify the type of hodgkin lymphoma:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"QualitativeEvaluation.anamResultAccuracyPercent","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 3098936:Individuals.What is the reason for the missing number of pregnancies?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2769109:Involvement and Extent of Disease.Specify primary cause of death:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2685309:Diagnosis.Specify the type of other connective tissue disease:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Base Result.Conventional Text Result Code List ID","type":"Map:CDISCLabv1.0.1","context":"NCIP"},{"name":"CDE 2935895:Molecular Abnormality.Specify the Philadelphia chromosome positive metaphases value (%):","type":"Map:HCTv1.0","context":"NCIP"},{"name":"ObservationResult.resultIndicator","type":"Map:CTRPv3.8","context":"NCIP"},{"name":"CDE 2693564:Lab Results.First DRB1* allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760867:Diagnosis.Specify the other liver disease diagnosis:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2953095:Lab Results.What is the value of serum calcium?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2597018:Lab Results.Lactate Dehydrogenase","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2704121:Lab Results.First DRB4* allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"ProductInvestigation.evaluationResultCode","type":"Map:AE","context":"NCIP"},{"name":"FemaleReproductiveCharacteristic.menopauseAge","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2986313:Lab Results.What was the histology type of the malignant testicular germ cell tumor?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2798684:Property or Attribute.Have you smoked cigarettes prior to but not during the past year?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3419391v1.0: Breast Cancer American Joint Committee on Cancer (AJCC) Edition 7 Clinical Distant Metastasis M Stage","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 3021221:Diagnosis.Specify the valvular insufficiency type:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2704108:Lab Results.Bw6 specificity present?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2932805:Disease, Disorder or Finding.What was the prior disease?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Base Result.Reported Units Code List ID","type":"Map:CDISCLabv1.0.1","context":"NCIP"},{"name":"TID 1410 PlanarROIMeasurements > Measurement Group > $QualitativeEvaluation","type":"Map:DICOM","context":"NCIP"},{"name":"TID 1500 MeasurementReport > Qualitative Evaluations > (unconstrained name/value pair)","type":"Map:DICOM","context":"NCIP"},{"name":"CDE 2794427:Specimen Characteristics.Percent Cells Viable:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"QualitativeEvaluation.survivalStatusDescriptionText","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 3105041:Disease-Disorder Classification.What was the classification of hematologic disorder?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2963407:Lab Results.What is the value of lymphocytes present in bone marrow?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3061213:Adverse Events.What is the percentage of body surface area affected by skin rash due to engraftment syndrome?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2970589:Lab Results.Specify copy number:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"TID 300 Measurement > $Measurement parameter","type":"Map:DICOM","context":"NCIP"},{"name":"SECTION IV DESCRIPTION OF THIS NEOPLASM - BEHAVIOR CODE","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION IX ADMINISTRATIVE CODES - SITE/HISTOLOGY/LATERALITY/SEQUENCE INTERRECORD REVIEW","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION VIII FOLLOW UP INFORMATION - SURVIVAL DATA ITEMS - Surv-Date DX Recode","type":"Map:SEER 2015","context":"NCIP"},{"name":"Base Results.SI Units Code List ID","type":"Map:CDISCLabv1.0.1","context":"NCIP"},{"name":"Diagnosis.dx_type","type":"Map:PCORNetv3.1","context":"NCIP"},{"name":"Vital.smoking","type":"Map:PCORNetv3.1","context":"NCIP"},{"name":"Obs_Clin.obsclin_result_qual","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Pro_CM.pro_measure_core","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Laboratory Test.RESULT_MODIFIER","type":"Map:i2b2/ACTv1.4","context":"NCIP"},{"name":"Laboratory Test.RAW_UNIT","type":"Map:i2b2/ACTv1.4","context":"NCIP"},{"name":"DEATH.cause_concept_id","type":"Map:OMOPv5.2","context":"NCIP"},{"name":"OBSERVATION.unit_concept_id","type":"Map:OMOPv5.2","context":"NCIP"},{"name":"CDE 2784433:Lab Results.For the bacterial or fungal infection cultures performed prior to infusion, specify the 3rd organism with name(s):","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2787947v1.0: Laboratory Test Result Unit of Measure Unified Code for Units of Measure Code","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2950700:Lab Results.Specify the lymphoma histology:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2971688:Lab Results.Specify level and units:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3116943v1.0: Gynecologic Tumor Grouping FIGO 2009 Cervical Carcinoma Stage","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2804619:Data Source.Is the data reported on this form based on contact with the physician?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"LabResult.numericResult","type":"Map:Lab","context":"NCIP"},{"name":"CDE 2677079:Diagnosis.What was the classification of the other malignancy?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2963361:Lab Results.Was the diagnositic image positive for CNS tumor?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3136597:Biological Process.What was the sensitivity of the disease to chemotherapy?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2957553:Lab Results.Specify abnormality:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2974113:Disease, Disorder or Finding.What was the aplastic anemia etiology?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2968377:Individuals.What was the other genetic disorder in the first degree relative?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2738883:Disease, Disorder or Finding.Specify predisposing condition:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"AbstractMeddraDomain.version_id","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2677067:Disease Response.Specify the type of complete remission of the breast cancer at the time of transplantation:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2756925:Lab Results.What is the unit of measure for the Ig test?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CtcTerm.term > AdverseEventCtcTerm","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2691376:Lab Results.For the polymyositis-dermatomyositis, were the EMG results typical of the disease?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2704139:Lab Results.First DRB5 * allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CtcTerm.ctepCode > AdverseEvent","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"QualitativeEvaluation.performanceStatusCode","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2969591:Involvement and Extent of Disease.What was the stage of breast cancer at diagnosis?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 64516//:Lab Results.Provide DNA Index of Leukemic Cells","type":"Map:HCTv1.0","context":"NCIP"},{"name":"MD Anderson Specific Content: Product.Transgene %","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2798745:Occurrences.Specify the other malignancy(ies):","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2695256:Lab Results.1st A antigen specificity:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2953022:Specimen Characteristics.Specify the size of the largest neoplasm mass:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2952925:Lab Results.What is the unit of measure for serum immunoglobulin light chain lambda?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2188132v1.0: Adverse Event Verbatim Term Text","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 3192455v1.0: Physical Examination Finding Type","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2902390v1.0: Pediatric Lymphoid Cancer St. Jude Stage","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2871881:Lab Results.What is the cm H2O value of the cerebrospinal fluid opening pressure:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2675085:Diagnosis.Specify the type of acute lymphoblastic leukemia (ALL):","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3123937:Lab Results.What is the eosinophils percentage value?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2793785:Quality of Life.What was the Karnofsky / Lansky score?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2688923:Diagnosis.What was the classification of plasma cell disorders?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2688882:Diagnosis.What is the classification of the other leukemia?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760451:Diagnosis.What is the chromosome abnormality diagnosis type?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2939337:Lab Results.Specify which type of cytogenetic and or molecular abnormalities showed a positive result:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"DeathSummary.deathCauseCode","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2760378:Specimen Characteristics.Was the cell viability tested?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"PreExistingCondition.text > SAEReportPreExistingCondition","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2954716:Outcome of Therapy.Specify the sensitivity of myeloma to chemotherapy:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2902396v1.0: CML Disease Phase Category","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2769017:Involvement and Extent of Disease.Primary cause of death:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"ParticipantHistory.height","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2860225:Lab Results.Absolute number of plasma cells in blood unit of measure:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Neoplasm.cellTypeCode","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2964762:Lab Results.What is the status of myeloid engraftment?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2738971:Disease, Disorder or Finding.Specify other predisposing condition:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2649435:Diagnosis.What was the subtype of the non-hodgkin lymphoma diffuse, large B-cell lymphoma?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2951827:Diagnosis.What was the result of the PET assessment?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2773882:Lab Results.CD8+ cells exponent value:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2634620:Lab Results.Hepatitis A antibody status","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2950911:Lab Results.Is the histology a transformation from CLL?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2793799:Diagnosis.Diagnosis of chronic GVHD was based on:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"LabResultUnitOfMeasure.code","type":"Map:LabViewer2.2","context":"NCIP"},{"name":"QualitativeEvaluation.menstrualIndicator","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 3024910:Disease, Disorder or Finding.What is the percentage of ejection fraction?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2867504:Lab Results.Serum creatinine 2 decimal place value:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2798800:Lab Results.What is the unit of measure for serum creatinine?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2952509:Lab Results.Was the monoclonal band type present?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2860911:Lab Results.What is the value of plasma cells in bone marrow aspirate?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"MD Anderson Specific Content: Product.Effector T cells","type":"Map:HCTv1.0","context":"NCIP"},{"name":"AdverseEvent.reactionText","type":"Map:AE","context":"NCIP"},{"name":"Participant.householdIncomeCode","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2780738:Lab Results.Chimerism study percent of donor cells:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"FemaleReproductiveCharacteristic.firstLiveBirthAge","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2963374:Lab Results.Was any tumor present in the biopsy?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2691627:Disease Response.If the plasma cell disorder was treated, what was the number of the response?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2694882:Lab Results.Second DQB1* allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Person.householdIncomeCode","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2704210:Lab Results.First DPA1* allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"AdverseEvent.adverseEventTermCode","type":"Map:AE","context":"NCIP"},{"name":"CDE 3073218:Lab Results.What is the reason for the A alleles missing value?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Base Result.Conventional Numeric Result","type":"Map:CDISCLabv1.0.1","context":"NCIP"},{"name":"CDE 3123938:Disease, Disorder or Finding.What is the result of the audiometric test assessed at the speech threshold for 500 hertz?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760660:Diagnosis.What is the endocrine disorder diagnosis type?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Specimen.volumeUnitOfMeasureCode","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 3158627:Therapies.What is the indication for cellular therapy?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2902417v1.0: Lymphoma Ann Arbor Staging System Stage","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2685385:Diagnosis.Specify the other acquired cytopenic syndrome:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Characteristics.value (in R_Product)","type":"Map:ICSRr2","context":"NCIP"},{"name":"PerformedObservationResult.result","type":"Map:LSDAMv2.2.3Plus","context":"NCIP"},{"name":"PerformedLesionDescription.lymphaticInvasion","type":"Map:LSDAMv2.2.3Plus","context":"NCIP"},{"name":"ImagingObservationEntity.typeCode","type":"Map:AIM v4 rv48","context":"NCIP"},{"name":"TID 1501 MeasurementGroup > Measurement Group > $QualitativeEvaluation","type":"Map:DICOM","context":"NCIP"},{"name":"SECTION IX ADMINISTRATIVE CODES - HISTOLOGY/BEHAVIOR INTERFIELD REVIEW","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION IX ADMINISTRATIVE CODES - AGE/SITE/HISTOLOGY INTERFIELD REVIEW","type":"Map:SEER 2015","context":"NCIP"},{"name":"Base Result.SI Text Result Code List ID","type":"Map:CDISCLabv1.0.1","context":"NCIP"},{"name":"PerformedObservationResult.value","type":"Map:CDMHv1.0","context":"NCIP"},{"name":"Encounter.Discharge_Status","type":"Map:Sentinelv6.0.2","context":"NCIP"},{"name":"Laboratory Result.MS_Result_unit","type":"Map:Sentinelv6.0.2","context":"NCIP"},{"name":"Vital Signs.HT","type":"Map:Sentinelv6.0.2","context":"NCIP"},{"name":"Death_Cause.death_cause","type":"Map:PCORNetv3.1","context":"NCIP"},{"name":"Lab_Result_CM.result_modifier","type":"Map:PCORNetv3.1","context":"NCIP"},{"name":"Condition.condition_type","type":"Map:PCORNetv3.1","context":"NCIP"},{"name":"Pro_CM.pro_response_num","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Obs_Gen.obsgen_result_text","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Laboratory Test.RAW_RESULT","type":"Map:i2b2/ACTv1.4","context":"NCIP"},{"name":"CDE 3419406v1.0: Breast Cancer American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Distant Metastasis M Stage","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2782552:Adverse Events.Specify the other hematopoietic stem cell infusion adverse event type","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2982573:Lab Results.What was the result of the bone marrow laboratory procedure?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"LaboratoryResult.numericResult","type":"Map:Lab","context":"NCIP"},{"name":"MD Anderson Specific Content: Product.CD8%","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3073222:Lab Results.What is the reason for the C alleles missing value?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"SECTION VI COLLABORATIVE STAGE DATA COLLECTION SYSTEM - REGIONAL NODES POSITIVE","type":"Map:SEER 2015","context":"NCIP"},{"name":"Lab_Result_CM.result_num","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Vital.smoking","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"MEASUREMENT.value_as_concept_id","type":"Map:OMOPv5.2","context":"NCIP"},{"name":"MEASUREMENT.unit_concept_id","type":"Map:OMOPv5.2","context":"NCIP"},{"name":"CDE 2969090:Lab Results.What is the value of vanillylmandelic acid measurement?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Histopathology.grossExamResultCode","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2952892:Lab Results.Serum free light chains (kappa):","type":"Map:HCTv1.0","context":"NCIP"},{"name":"ParticipantEligibilityAnswer.answerText","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2675089:Diagnosis.What was the W.H.O. classification of the other acute leukemia?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2782608:Lab Results.What is the unit of measure for AST (SGOT)?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3117210:Lab Results.Specify the testicular cancer stage:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3009207:Disease, Disorder or Finding.Specify the hematologic status:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2677074:Disease, Disorder or Finding.If the breast cancer was in the state of relapse at the time of transplantation, what was the sensitivity to chemotherapy?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2784431:Lab Results.For the bacterial or fungal infection cultures performed prior to infusion, specify the 2nd organism with name(s):","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2964425:Diagnosis.Specify the histological diagnosis of resected tissue","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3179231:Lab Results.Does the recipient have clinical significant rhizopus fungal infection history?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2979356:Diagnosis.Specify the ratio of HER2 signals to 17 centromere signals:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2693524:Lab Results.First A* allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2686163:Diagnosis.Specify the other autoimmune neurological disorder:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2704143:Lab Results.Second DRB5 * allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3133353v1.0: Common Terminology Criterio for Adverse Events Version 4.0 Mapped Low Level Term MedDRA Code","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"DiseaseResponse.courseDispositionCode","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2953285:Affiliation Type.Is the person enrolled in school?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Lab.units","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"Assessment.textInterpretation","type":"Map:AE","context":"NCIP"},{"name":"CDE 2695025:Lab Results.Test results of infectious disease marker for human T-Lymphotropic virus antibody (Anti-HTLV I / II):","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2797618:Outcome of Therapy.List the maximum severity of acute graft versus host disease skin involvement:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"FemaleReproductiveCharacteristic.abortionIndicator","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2861060:Lab Results.Serum beta 2-microglobulin unit of measure:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"QualitativeEvaluation.performanceStatusCodeSystem","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2861067:Lab Results.Serum albumin value:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2952923:Lab Results.Serum free light chains (lambda):","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3158540:Therapies.Specify other indication for cellular therapy:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2693554:Lab Results.First C* allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3061542:Medical Imaging.What were the results of the image studies performed?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2704151:Lab Results.DR52 specificity present?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3126069:Procedures.What was the visual eye acuity snellen fraction numerator?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760821:Diagnosis.What is the hematologic diagnostic type?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3212384:Lab Results.Were donor cells present as determined by non-quantitative means?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2695096:Lab Results.Test results of infectious disease marker for west nile virus (WNV) using nucleic acid amplification test (NAT)","type":"Map:HCTv1.0","context":"NCIP"},{"name":"MD Anderson Specific Content: Product.Regulatory T cells","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2978596:Lab Results.Specify estrogen receptor assay results:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2704125:Lab Results.Second DRB4* allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2434914:Eligibility.Menopausal status","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2797508:Involvement and Extent of Disease.Specify any other non-infectious pulmonary abnormalities that developed:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2986315:Lab Results.Specify malignant testicular germ cell tumor histology:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2939332:Organ Measurements.What was the spleen size?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2676555:Involvement and Extent of Disease.What was the stage of the breast cancer at diagnosis?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"LesionEvaluation.evaluationCode","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2760831:Diagnosis.Specify the other hematologic diagnosis:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3192550v1.0: Medical History Review of Systems Finding Type","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 3158590:Medical Records and Forms.What is the indication for CIBMTR recipient ID (CRID) assignment?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2693507:Lab Results.Number of B antigens provided:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2974108:Lab Results.What was the gamma-enolase value ?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3086799:Lab Results.What is the value of serum IgG?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2201880v1.0: Patient Abnormal Physical Examination Specify","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"LabValue.value","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2691374:Lab Results.For the dermatomyositis, was there a rash present that was typical of the disease?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2682797:Chronic Myelogenous Leukemia (CML): Part 1 of 2.At the time of transplantation, what was the number of the status of the CML?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2785801:Lab Results.When the colony-forming units were assessed, was there growth?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"AbstractMeddraDomain.hartsCode","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"StudyParticipantDiseaseHistory.otherPrimaryDisease","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 3181189:Lab Results.Specify reticulocytes one decimal place billion per liter value:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2946347:Involvement and Extent of Disease.What kind of disease present?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2950100:Disease, Disorder or Finding.What kind of clinical features were presented ?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"MD Anderson Specific Content: Product.CD56%","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2965488:Lab Results.What is the mitogen proliferation response?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2797722:Involvement and Extent of Disease.Specify the other non-infectious liver toxicity:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2952507:Lab Results.Which monoclonal bands were present?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2797633:Outcome of Therapy.List the maximum severity of the acute graft versus host disease lower intestinal tract involvement:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2686111:Diagnosis.Specify the other SCID:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 58265 /:Lab Results.Marrow Cellularity Status","type":"Map:HCTv1.0","context":"NCIP"},{"name":"AbstractMeddraDomain.meddraTerm","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2730798:Lab Results.When the colony-forming units (CFU) were assessed, what was the total number of colonies counted?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2695060:Lab Results.If FDA licensed nucleic acid amplification test (NAT) for human immunodeficiency virus(HIV)-1 performed; specify results","type":"Map:HCTv1.0","context":"NCIP"},{"name":"MD Anderson Specific Content: Recipient.Recipient weight (kg)","type":"Map:HCTv1.0","context":"NCIP"},{"name":"MD Anderson Specific Content: Product.CAR%","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2962086:Involvement and Extent of Disease.What was the history of co-existing phakomatosis?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3030931:Lab Results.What is the value of platelets?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2738448:Diagnosis.What was the MDS or myeloproliferative disease classification?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2798928:Lab Results.What is the hemoglobin lab value?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Diagnosis.diseaseDiagnosisCodeSystem","type":"Map:CTOM","context":"NCIP"},{"name":"StudyParticipantAssignment.baselinePerformance","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2646370:Lab Results.PgR % cells stained positive","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2782521:Lab Results.Was the disease detected by cytogenetic analysis?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3126070:Procedures.What was the visual eye acuity snellen fraction denominator?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2798756:Lab Results.What is the value of serum glutamic oxaloacetic transferase?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2695291:Lab Results.First C antigen specificity","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760275:Lab Results.Nucleated red blood cells exponent value:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760665:Diagnosis.Specify the other endocrine diagnosis:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2772153:Lab Results.Total value of CD8+ cells:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"SECTION IX ADMINISTRATIVE CODES - SEQUENCE NUMBER/DIAGNOSTIC CONFIRMATION INTERFIELD REVIEW","type":"Map:SEER 2015","context":"NCIP"},{"name":"Diagnosis.Dx_Codetype","type":"Map:Sentinelv6.0.2","context":"NCIP"},{"name":"Pro_CM.pro_response","type":"Map:PCORNetv3.1","context":"NCIP"},{"name":"Vital.diastolic","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Obs_Clin.obsclin_result_snomed","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Pro_CM.pro_measure_count_scored","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Base Result.Reported Text Result Code List ID","type":"Map:CDISCLabv1.0.1","context":"NCIP"},{"name":"PerformedLesionDescription.venousInvasion","type":"Map:LSDAMv2.2.3Plus","context":"NCIP"},{"name":"PerformedPathologicalStaging.numberLymphNodesExamined","type":"Map:LSDAMv2.2.3Plus","context":"NCIP"},{"name":"ImagingObservationCharacteristic.typeCode","type":"Map:AIM v4 rv48","context":"NCIP"},{"name":"InferenceEntity.typeCode","type":"Map:AIM v4 rv48","context":"NCIP"},{"name":"SECTION IV DESCRIPTION OF THIS NEOPLASM - SEQUENCE NUMBER-CENTRAL","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION IV DESCRIPTION OF THIS NEOPLASM - HISTOLOGIC TYPE ICD-O-3","type":"Map:SEER 2015","context":"NCIP"},{"name":"Base Result.SI Numeric Result Precision","type":"Map:CDISCLabv1.0.1","context":"NCIP"},{"name":"Base Specimen.Investigator - Specimen Comments","type":"Map:CDISCLabv1.0.1","context":"NCIP"},{"name":"Base Specimen.Lab - Specimen Comments","type":"Map:CDISCLabv1.0.1","context":"NCIP"},{"name":"Diagnosis.DX","type":"Map:Sentinelv6.0.2","context":"NCIP"},{"name":"Cause of Death.COD","type":"Map:Sentinelv6.0.2","context":"NCIP"},{"name":"Laboratory Result.MS_Result_N","type":"Map:Sentinelv6.0.2","context":"NCIP"},{"name":"Diagnosis.dx","type":"Map:PCORNetv3.1","context":"NCIP"},{"name":"Vital.original_bmi","type":"Map:PCORNetv3.1","context":"NCIP"},{"name":"Condition.condition","type":"Map:PCORNetv3.1","context":"NCIP"},{"name":"Lab_Result_CM.result_unit","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Obs_Clin.obsclin_result_num","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Diagnosis.DIAGNOSIS_CODE","type":"Map:i2b2/ACTv1.4","context":"NCIP"},{"name":"AbstractMeddraDomain.jartCode","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2737648:Disease, Disorder or Finding.What was the cause of the therapy related AML?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2689280:Involvement and Extent of Disease.What was the International Staging System for Myeloma Stage?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760303:Lab Results.Total value of CD3+ cells:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2802770:Lab Results.Specify cluster of differentiation type:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2911999:Diagnosis.What was the classification of the aplastic anemia?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2749870:Lab Results.For the antiphospholipid syndrome, what was the result of the laboratory procedure?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2848650v1.0: Binet Staging System Stage","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2693547:Lab Results.Second B* allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2694901:Lab Results.Second DPB1* allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"PreExistingCondition.meddraLowLevelTerm > SAEReportPreExistingCondition","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2784437:Lab Results.For the bacterial or fungal infection cultures performed prior to infusion, specify the 5th organism with name(s):","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2983177:Lab Results.Specify the proliferative index value:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"MD Anderson Specific Content: Product.CD19%","type":"Map:HCTv1.0","context":"NCIP"},{"name":"DeathSummary.deathCauseText","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2002710:Chronic or Associated Diseases and Exposures.Specify other","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2594609:Lab Results.Was the lymphoma or lymphoproliferative disease EBV positive?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"DiseaseResponse.responseCodeSystem","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2789977:Personal attributes.Donor's blood type and Rh factor:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2965922:Lab Results.What is the IgE level?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2991013:Lab Results.What is the unit of measure for leukocyte enzyme activity level?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760382:Lab Results.When the colony-forming units (CFU) were assessed, what was the total number of CFU-GM counted?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2974091:Involvement and Extent of Disease.Specify the Evans Stage:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3115777:Lab Results.What was the serum alpha-fetoprotein value?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3017713:Molecular Abnormality.What was the outcome of the cytogenetic analysis?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3179224:Lab Results.Does the recipient have clinical significant zygomycosis fungal infection history?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3028430:Lab Results.What is the value of the enzyme evaluated for activity level?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"StudyParticipantPreExistingCondition.other","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2964760:Lab Results.What is the status of B-cell engraftment?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2685168:Diagnosis.What was the classification of the inherited disorders of metabolism / osteopetrosis?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2179892v1.0: Adverse Event Cancer Treatment Related Type","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"LabResult.numericPrecision","type":"Map:Lab","context":"NCIP"},{"name":"CDE 2686194:Lab Results.For the systemic lupus erythematosus, what was the C3 test result?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3050012:Techniques.Specify portion of cells cryopreserved prior to infusion","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2695304:Lab Results.Number of DR antigens provided","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2693560:Lab Results.Second C* allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Specimen.volume","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2695078:Lab Results.Test results of infectious disease marker for Anti-HIV 1 and anti-HIV 2 (antibodies to Human Immunodeficiency Viruses):","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2695074:Procedures.Was FDA licensed nucleic acid amplification test (NAT) for hepatitis C virus performed; specify results","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3188446:Diagnosis.Specify the enzyme deficiency:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"ObservationResult.resultCode","type":"Map:CTRPv3.8","context":"NCIP"},{"name":"CDE 3073228:Lab Results.What is the reason for the DRB4 alleles missing value?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Diagnosis.diseaseDiagnosisCode","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2760790:Diagnosis.Specify the other gastrointestinal diagnosis:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2787461:Diagnosis.What is the primary disease for which the HSCT was performed?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2689280v1.0: Plasma Cell Myeloma International Staging System for Myeloma Stage","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CancerStage.stageCode","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2799091:Lab Results.What is the value of platelets? 0","type":"Map:HCTv1.0","context":"NCIP"},{"name":"AdverseEvent.outcomeCode","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2760808:Diagnosis.Specify the other genitourinary diagnosis:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2679790:Disease, Disorder or Finding.Specify the other inherited platelet abnormalities:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3073235:Lab Results.What is the reason for the DQB1 allelles missing value?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2630200:Units of Measure.Weight Unit of Measure UCUM Code","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3008193:Disease, Disorder or Finding.Specify the hepatic status:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Animal.overallStateOfHealthCode","type":"Map:AE","context":"NCIP"},{"name":"CDE 2797645:Outcome of Therapy.List the maximum severity of the acute graft versus host disease upper intestinal tract involvement:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760294:Diagnosis.Specify the other cardiovascular diagnosis:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"DiseaseResponse.responseCode","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2004106v3.0: Dose Limiting Toxicity Ind","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"DiseaseHistory.otherPrimaryDiseaseCode","type":"Map:C3PRv2.9","context":"NCIP"},{"name":"CDE 2686055:DONOR'.For an HLA-mismatched related donor, what was the degree of mismatch:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2974177:Diagnosis.What was the primary CNS disease for which the HSCT was performed?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2980333:Involvement and Extent of Disease.Specify the recurrent disease present in another site:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3241064v1.0: Laboratory Test Result Character Value","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 3128021:Disease, Disorder or Finding.Specify the Chronic Lymphocytic Leukemia histology:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2965468:Lab Results.What is the status of T-cell function?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Base Result.Conventional Numeric Result Precision","type":"Map:CDISCLabv1.0.1","context":"NCIP"},{"name":"CDE 2760279:Lab Results.Total value of nucleated red blood cells:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"MeddraVersion.name > AdverseEvent","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2967358:Individuals.Is there a family history of other genetic diseases in first-degree blood relatives?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2974055:Involvement and Extent of Disease.Specify the International Neuroblastoma Staging System disease stage:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2798924:Lab Results.What is the lymphocytes lab value?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3141228:Quality of Life.Lansky Performance Status Score","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2677117:Biological Process.If there was a relapse of the other malignancy, what was the sensitivity to chemotherapy?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3179207:Lab Results.Does the recipient have clinical significant fusarium fungal infection history?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2970552:Lab Results.Were proto-oncogenes detected?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3073224:Lab Results.What is the reason for the DRB1 allelles missing value?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2782624:Lab Results.What is the value of total serum bilirubin?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"SECTION IX ADMINISTRATIVE CODES - SURGERY/DIAGNOSTIC CONFIRMATION INTERFIELD REVIEW","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION IX ADMINISTRATIVE CODES - OVER-RIDE FLAG FOR SITE/BEHAVIOR (IF39)","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION IX ADMINISTRATIVE CODES - OVER-RIDE FLAG FOR SITE/LATERALITY/EOD (IF41)","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION VI COLLABORATIVE STAGE DATA COLLECTION SYSTEM - GRADE PATH VALUE","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION VII FIRST COURSE OF THERAPY - SCOPE OF REGIONAL LYMPH NODE SURGERY","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION VIII FOLLOW UP INFORMATION - ICD CODE REVISION USED FOR CAUSE OF DEATH","type":"Map:SEER 2015","context":"NCIP"},{"name":"CDE 2986513:Outcome of Therapy.What was the sensitivity of the testicular carcinoma to chemotherapy?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3128020:Disease, Disorder or Finding.What was the chronic lymphocytic leukemia histology type?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3024868:Disease, Disorder or Finding.Were the exam results normal or abnormal?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2770355:Lab Results.Was the disease detected by molecular analysis?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3128022:Diagnosis.Specify other autoimmune disease:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2739534:Adverse Events.What type of Adverse Events were associated with the stem cell infusion?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2494701:Pre-Preparative Regimen.Which scale was used to measure/report the functional status?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760473:Diagnosis.Specify the chromosome abnormality:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2897746:Lab Results.What is the percent of basophils?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3031315:Lab Results.What is the unit of measure for urinary monoclonal light chains?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2769651:Individuals.What is the number of pregnancies?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"SECTION VIII FOLLOW UP INFORMATION - SURVIVAL DATA ITEMS - Surv-Flag Presumed Alive","type":"Map:SEER 2015","context":"NCIP"},{"name":"Laboratory Result.MS_Result_C","type":"Map:Sentinelv6.0.2","context":"NCIP"},{"name":"Lab_Result_CM.result_unit","type":"Map:PCORNetv3.1","context":"NCIP"},{"name":"Vital.ht","type":"Map:PCORNetv3.1","context":"NCIP"},{"name":"Vital.wt","type":"Map:PCORNetv3.1","context":"NCIP"},{"name":"Lab_Result_CM.raw_result","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Lab_Result_CM.result_modifier","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Obs_Clin.obsclin_result_unit","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"NOTE.encoding_concept_id","type":"Map:OMOPv5.2","context":"NCIP"},{"name":"CDE 2867502:Lab Results.Serum creatinine:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2704158:Lab Results.DR53 specificity present?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"MD Anderson Specific Content: Product.CD4%","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2954746:Therapies.At what point in the disease course was the HSCT performed?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2704252:Lab Results.Second DP antigen specificity:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Ctc.name > AdverseEventCtcTerm","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"ParticipantHistory.baselinePerformanceStatus","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 3031376:Disease, Disorder or Finding.What is the result of the method used to assess disease?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2695266:Lab Results.2nd A antigen specificity","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Base Result.Conventional Units Code List ID","type":"Map:CDISCLabv1.0.1","context":"NCIP"},{"name":"CDE 2782626:Lab Results.What is the unit of measure for total serum bilirubin?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CalculationData.value","type":"Map:AIM v4 rv48","context":"NCIP"},{"name":"SECTION IX ADMINISTRATIVE CODES - SITE/TYPE INTERFIELD REVIEW","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION VI COLLABORATIVE STAGE DATA COLLECTION SYSTEM - GRADE PATH SYSTEM","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION VII FIRST COURSE OF THERAPY - SURGERY OF PRIMARY SITE","type":"Map:SEER 2015","context":"NCIP"},{"name":"Cause of Death.CodeType","type":"Map:Sentinelv6.0.2","context":"NCIP"},{"name":"SECTION VII FIRST COURSE OF THERAPY - CHEMOTHERAPY","type":"Map:SEER 2015","context":"NCIP"},{"name":"Laboratory Result.Modifier","type":"Map:Sentinelv6.0.2","context":"NCIP"},{"name":"OBSERVATION.value_as_concept_id","type":"Map:OMOPv5.2","context":"NCIP"},{"name":"CDE 3128032:Symptoms.What were the chronic lymphocytic leukemia symptoms?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"StratificationCriterionPermissbleAnswer.permissibleAnswer","type":"Map:C3PR","context":"NCIP"},{"name":"CDE 2974120:Disease, Disorder or Finding.Specify viral hepatitis type:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"DiseaseHistory > AbstractStudyDisease","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2689329:Lab Results.For systemic lupus, erythematosus, what was the total complement test result?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2688790:Diagnosis.What was the classification of the chronic myelogenous leukemia (Philadelphia chromosome+, Ph+, t(9;22)(q34;q11), or variant OR bcr/abl+)?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3419389v1.0: Breast Cancer American Joint Committee on Cancer (AJCC) Edition 7 Clinical Regional Lymph Node N Stage","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2801066:Diagnosis.Specify the diagnosis of liver toxicity by the type of clinical signs, symptoms or evaluation:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2951780:Lab Results.Heavy chain","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3124170:Lab Results.Did any cytogenetic or molecular testing for BCR/ABL or Ph+ show a positive result?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2986573:Outcome of Therapy.Indicate the sensitivity of the testicular carcinoma to any platinum-containing chemotherapeutic agent administered:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2704223:Lab Results.Second DPA1* allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2760898:Diagnosis.Specify the other pulmonary diagnosis:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2780726:Lab Results.Chimerism study total number of donor cells:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"PreExistingCondition.text > StudyParticipantPreExistingCondition","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2769598:Adverse Events.What is the most likely cause of the adverse event?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"QualitativeEvaluation.survivalStatusCode","type":"Map:CTOM","context":"NCIP"},{"name":"AbstractMeddraDomain.meddraCode > AdverseEventMeddraLowLevelTerm","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2749839:Lab Results.Were tumor cells detected in collected cells, before purging prior to HSCT?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3179295:Lab Results.Does the recipient have clinical significant zygomycota fungal infection history?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2782511:Symptoms.Specify the symptoms of engraftment syndrome:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3123936:Disease, Disorder or Finding.What is the result of the audiometric test assessed at the speech threshold for 2000 hertz?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2815190:Personal attributes.What is the person's retirement income status?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2737638:Disease, Disorder or Finding.Specify the other type of clinically significant comorbidity:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"MD Anderson Specific Content: Product.CD3%","type":"Map:HCTv1.0","context":"NCIP"},{"name":"PreExistingCondition.meddraLowLevelTerm > StudyParticipantPreExistingCondition","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2953262:Individuals.Specify the type of health insurance:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2679802:Diagnosis.Specify the type of autoimmune disease:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2967294:Anatomic Sites.Number of tumors present:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2695297:Lab Results.Second C antigen specificity:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"PreExistingCondition.meddraLowLevelTermCode > SAEReportPreExistingCondition","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2775872:Lab Results.What is the value of WBC:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2780733:Lab Results.Chimerism study total number of host cells:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3181117:Lab Results.Specify paroxysmal nocturnal hemoglobinuria results:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2775874:Lab Results.What is the unit of measure for WBC?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3021261:Quality of Life.What is the value of the mental process development assessment score?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2749826:Lab Results.Were tumor cells detected in circulating blood cells prior to HSCT?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2739683:Therapy Results.Was a complete remission (CR) ever achieved in response to the HSCT?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2514317:Diagnosis.CML Lineage","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2769114:Involvement and Extent of Disease.Contributing cause of death:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2784435:Lab Results.For the bacterial or fungal infection cultures performed prior to infusion, specify the 4th organism with name(s):","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2704262:Therapy Doses.Was the entire volume of product infused?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2902402v1.0: Lymphoma B-Symptoms Medical Record Documented Indicator","type":"Map:NCI CRF Standard","context":"NCIP"},{"name":"CDE 2749843:Lab Results.For the systemic sclerosis, what was the result of the laboratory procedure?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2685348:Diagnosis.Specify the other type of plasma cell disorder:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2785810:Involvement and Extent of Disease.What was the maximum extent of chronic GVHD during this period?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2936025:Lab Results.Results of cytogenetic testing:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3076040:Lab Results.What is the percentage of monocytes?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2681996:Therapies.Was KGF (palifermin, Kepivance) started or is there a plan to use it?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2749876:Lab Results.For the wegener granulomatosis, what was the result of the laboratory procedure?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"PerformedObservationResult.value","type":"Map:CTRv1.0","context":"NCIP"},{"name":"CDE 2962101:Disease, Disorder or Finding.Specify the family history of cancer in first degree relatives under 40 years of age:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2658051:Lab Results.Light Chain Involved","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2681619:Pre-Preparative Regimen.What was the recipient's test results for the presence of CMV-antibodies?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2962099:Disease, Disorder or Finding.What was the family history of cancer in first degree relatives under 40 years of age?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2693511:Lab Results.Number of C antigens provided:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2693543:Lab Results.First B* allele designations:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2866119:Lab Results.What is the unit of measure for the cerebrospinal fluid total protein:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3030985:Lab Results.What is the value of serum free light chains (kappa):","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Person.employmentStatusCode","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2780745:Lab Results.Chimerism study percent of host cells:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2967337:Individuals.Specify the family member(s) diagnosed with neuroblastoma or ganglioneuroma:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 3028428:Lab Results.Specify the other disease enzyme evaluated for activity level","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2689395:Diagnosis.Specify the other vasculitis:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"PreExistingCondition.meddraLowLevelTermCode > StudyParticipantPreExistingCondition","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"PerformedObservationResult.value (subject status at activity end)","type":"Map:CDMHv1.0","context":"NCIP"},{"name":"SECTION IX ADMINISTRATIVE CODES - SEQUENCE NUMBER/ILL-DEFINED SITE INTERFIELD REVIEW","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION IX ADMINISTRATIVE CODES - TYPE OF REPORTING SOURCE/SEQUENCE NUMBER INTERFIELD REVIEW","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION IX ADMINISTRATIVE CODES - OVER-RIDE FLAG FOR SITE/LATERALITY/MORPHOLOGY (IF42)","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION VI COLLABORATIVE STAGE DATA COLLECTION SYSTEM - LYMPH-VASCULAR INVASION","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION VII FIRST COURSE OF THERAPY - IMMUNOTHERAPY","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION VIII FOLLOW UP INFORMATION - SURVIVAL DATA ITEMS - Surv-Mos Active Followup","type":"Map:SEER 2015","context":"NCIP"},{"name":"Vital Signs.Tobacco","type":"Map:Sentinelv6.0.2","context":"NCIP"},{"name":"Vital.tobacco","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Pro_CM.pro_response_text","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Pro_CM.pro_measure_standard_error","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Obs_Gen.obsgen_result_qual","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Obs_Gen.obsgen_result_num","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"MEASUREMENT.value_as_number","type":"Map:OMOPv5.2","context":"NCIP"},{"name":"CONDITION_OCCURRENCE.condition_concept_id","type":"Map:OMOPv5.2","context":"NCIP"},{"name":"CDE 2771985:Lab Results.Total value of mesenchymal cells:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2953097:Lab Results.Serum Calcium Unit of Measure","type":"Map:HCTv1.0","context":"NCIP"},{"name":"AdverseEventResponseDescription.studyDrugInterrupted","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2798687:Chronic or Associated Diseases and Exposures.How many years did the recipient smoke cigarettes?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2675091:Diagnosis.Specify the type of other acute leukemia:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"QualitativeEvaluation.menstrualPatternTypeCode","type":"Map:CTOM","context":"NCIP"},{"name":"CDE 2969596:Diagnosis.Specify breast cancer histology:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2871879:Lab Results.Was the cerebrospinal fluid opening pressure known?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2963521:Lab Results.Leukemia cell type:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2797671:Outcome of Therapy.List the maximum severity of acute graft versus host disease liver involvement:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"Base Result.Conventional Text Result","type":"Map:CDISCLabv1.0.1","context":"NCIP"},{"name":"CDE 2626962:Procedures.Number of metaphases examined","type":"Map:HCTv1.0","context":"NCIP"},{"name":"CDE 2863881:Lab Results.What is the value of serum ferritin?","type":"Map:HCTv1.0","context":"NCIP"},{"name":"AbstractMeddraDomain.whoArtCode","type":"Map:caAERSv2.2","context":"NCIP"},{"name":"CDE 2969619:Eligibility.Specify the patient's age at menopause:","type":"Map:HCTv1.0","context":"NCIP"},{"name":"SECTION IV DESCRIPTION OF THIS NEOPLASM - MORPHOLOGY","type":"Map:SEER 2015","context":"NCIP"},{"name":"Base Result.SI Text Result","type":"Map:CDISCLabv1.0.1","context":"NCIP"},{"name":"Vital Signs.WT","type":"Map:Sentinelv6.0.2","context":"NCIP"},{"name":"Vital.tobacco","type":"Map:PCORNetv3.1","context":"NCIP"},{"name":"Encounter.discharge_status","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Pro_CM.pro_measure_theta","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"CalculationResult.unitOfMeasure","type":"Map:AIM v4 rv48","context":"NCIP"},{"name":"TID 1411 VolumetricROIMeasurements > Measurement Group > $QualitativeEvaluation","type":"Map:DICOM","context":"NCIP"},{"name":"TID 1419 ROIMeasurements > $Measurement parameter","type":"Map:DICOM","context":"NCIP"},{"name":"SECTION VI COLLABORATIVE STAGE DATA COLLECTION SYSTEM - CS TUMOR SIZE","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION VI COLLABORATIVE STAGE DATA COLLECTION SYSTEM - REGIONAL NODES EXAMINED","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION VI COLLABORATIVE STAGE DATA COLLECTION SYSTEM - CS SITE-SPECIFIC FACTORS 1 - 25","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION VII FIRST COURSE OF THERAPY - HEMATOLOGIC TRANSPLANT AND ENDOCRINE PROCEDURES","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION VII FIRST COURSE OF THERAPY - OTHER THERAPY","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION VIII FOLLOW UP INFORMATION - UNDERLYING CAUSE OF DEATH","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION VIII FOLLOW UP INFORMATION - SURVIVAL DATA ITEMS - Surv-Date Active Followup","type":"Map:SEER 2015","context":"NCIP"},{"name":"SECTION VIII FOLLOW UP INFORMATION - SURVIVAL DATA ITEMS - Surv-Date Presumed Alive","type":"Map:SEER 2015","context":"NCIP"},{"name":"Vital.diastolic","type":"Map:PCORNetv3.1","context":"NCIP"},{"name":"Pro_CM.pro_mode","type":"Map:PCORNetv3.1","context":"NCIP"},{"name":"Vital.original_bmi","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Obs_Gen.obsgen_result_modifier","type":"Map:PCORNetv4.0","context":"NCIP"},{"name":"Laboratory Test.RESULT_QUALITATIVE","type":"Map:i2b2/ACTv1.4","context":"NCIP"},{"name":"Laboratory Test.RESULT_NUMERICAL","type":"Map:i2b2/ACTv1.4","context":"NCIP"},{"name":"OBSERVATION.value_as_string","type":"Map:OMOPv5.2","context":"NCIP"}],"ReferenceDocuments":[{"name":"Data Element Performed Observation Outcome Data ISO21090.ANY.v1.0 does not have Preferred Question Text","type":"Preferred Question Text","description":"Data Element Performed Observation Outcome Data ISO21090.ANY.v1.0 does not have Preferred Question Text","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97F3A0CC-007A-98C1-E040-BB89AD43324C","latestVersionIndicator":"Yes","beginDate":"2010-12-21","endDate":null,"createdBy":"UMLLOADER_BRIDGPRD","dateCreated":"2010-12-21","modifiedBy":"SBREXT","dateModified":"2019-10-03","changeDescription":"Moved UML alt def to CDE preferred def and released per model owner approval. sa 2/7/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}